Kidimab®
Company name
:
Model
:
Adalimumab
Price
:
Packaging
:
Minimum order
:
Negotiable
Standard
:
Production power
:
Negotiable
Payment type
:
Advance Payment
Post type
:
Negotiable
Description
:
KidiMab® (Adalimumab) is a recombinant monoclonal antibody that binds to human tumor necrosis factor alpha (TNF-alpha), thereby interfering with binding to TNFα receptor sites and subsequent cytokine-driven inflammatory processes.